Effects of oncolytic immunotherapy with RP1 (vusolimogene oderparepvec) on immune cells mediate responsiveness to anti-PD-1 via STING-mediated interferon signaling
Victoria Roulstone, Joan Kyula, Elizabeth Appleton, Praveen K Bommareddy, Anton Patrikeev, Sylwia Jones, Linta Kuncheria, Charleen Ml Chan Wah Hak, Shane Foo, Holly Baldock, Amarin Wongariyapak, Isla Leslie, Robert Pickering, Christian Zierhut, Henry G Smith, Nitya Mohan, Carmen Murano, Lisa C Hubbard, Isaac Dean, Emmanuel Christian Patin